α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke

References

• LoganJChenLGangellCSlyPDFantinoELiuKBrief exposure to cigarette smoke impairs airway epithelial cell innate anti-viral defenceToxicol In Vitro20142881430143525111775
   PubMed Web of Science ®Google Scholar
• ProudDHudyMHWiehlerSCigarette smoke modulates expression of human rhinovirus-induced airway epithelial host defense genesPLoS One201277e4076222808255
   PubMed Web of Science ®Google Scholar
• HudyMHTravesSLWiehlerSProudDCigarette smoke modulates rhinovirus-induced airway epithelial cell chemokine productionEur Respir J20103561256126319840959
   PubMed Web of Science ®Google Scholar
• NyunoyaTMebratuYContrerasADelgadoMChandHSTesfaigziYMolecular processes that drive cigarette smoke-induced epithelial cell fate of the lungAm J Respir Cell Mol Biol201450347148224111585
   PubMed Web of Science ®Google Scholar
• ZlatevaKTde VriesJJCoenjaertsFEGRACE Study GroupProlonged shedding of rhinovirus and re-infection in adults with respiratory tract illnessEur Respir J201444116917724876172
   PubMed Web of Science ®Google Scholar
• GeorgeSNGarchaDSMackayAJHuman rhinovirus infection during naturally occurring COPD exacerbationsEur Respir J2014441879624627537
   PubMed Web of Science ®Google Scholar
• KennedyJLTurnerRBBracialeTHeymannPWBorishLPathogenesis of rhinovirus infectionCurr Opin Virol20122328729322542099
   PubMed Web of Science ®Google Scholar
• GernJEThe ABCs of rhinoviruses, wheezing, and asthmaJ Virol201084157418742620375160
   PubMed Web of Science ®Google Scholar
• MukhopadhyaySMalikPAroraSKMukherjeeTKIntercellular adhesion molecule-1 as a drug target in asthma and rhinitisRespirology201419450851324689994
   PubMed Web of Science ®Google Scholar
• JiangDPersingerRWuQGrossAChuHWalpha1-Antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in miceRespir Res20131412224209388
   PubMed Web of Science ®Google Scholar
• ShapiroLPottGBRalstonAHAlpha-1-antitrypsin inhibits human immunodeficiency virus type 1FASEB J200115111512211149899
   PubMed Web of Science ®Google Scholar
• ChuHWBalzarSSeedorfGJTransforming growth factor-beta2 induces bronchial epithelial mucin expression in asthmaAm J Pathol200416541097110615466377
   PubMed Web of Science ®Google Scholar
• GrossCABowlerRPGreenRMWeinbergerARSchnellCChuHWbeta2-Agonists promote host defense against bacterial infection in primary human bronchial epithelial cellsBMC Pulm Med2010103020470412
   PubMed Web of Science ®Google Scholar
• GaoWZhaoJKimHalpha1-Antitrypsin inhibits ischemia reperfusion-induced lung injury by reducing inflammatory response and cell deathJ Heart Lung Transplant201433330931524365768
   PubMed Web of Science ®Google Scholar
• ChurgAWangXWangRDMeixnerSCPryzdialELWrightJLAlpha1-antitrypsin suppresses TNF-alpha and MMP-12 production by cigarette smoke-stimulated macrophagesAm J Respir Cell Mol Biol200737214415117395890
   PubMed Web of Science ®Google Scholar
• ZhangWCaseSBowlerRPMartinRJJiangDChuHWCigarette smoke modulates PGE(2) and host defence against Moraxella catarrhalis infection in human airway epithelial cellsRespirology201116350851621199162
   PubMed Web of Science ®Google Scholar
• WuQJiangDChuHWCigarette smoke induces growth differentiation factor 15 production in human lung epithelial cells: implication in mucin over-expressionInnate Immun201218461762622180562
   PubMed Web of Science ®Google Scholar
• WuQvan DykLFJiangDInterleukin-1 receptor-associated kinase M (IRAK-M) promotes human rhinovirus infection in lung epithelial cells via the autophagic pathwayVirology20134461–219920624074582
   PubMed Web of Science ®Google Scholar
• OkabayashiTKojimaTMasakiTType-III interferon, not type-I, is the predominant interferon induced by respiratory viruses in nasal epithelial cellsVirus Res20111601–236036621816185
   PubMed Web of Science ®Google Scholar
• KhaitovMRLaza-StancaVEdwardsMRRespiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cellsAllergy200964337538619175599
   PubMed Web of Science ®Google Scholar
• HallerOKochsGHuman MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activityJ Interferon Cytokine Res2011311798721166595
   PubMed Web of Science ®Google Scholar
• HudyMHProudDCigarette smoke enhances human rhinovirus-induced CXCL8 production via HuR-mediated mRNA stabilization in human airway epithelial cellsRespir Res2013148823988199
   PubMed Web of Science ®Google Scholar
• PapiAPapadopoulosNGStanciuLAReducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cellsFASEB J200216141934193612368227
   PubMed Web of Science ®Google Scholar
• WhitemanSCBiancoAKnightRASpiteriMAHuman rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivityJ Biol Chem200327814119541196112551926
   PubMed Web of Science ®Google Scholar
• EddlestonJLeeRUDoernerAMHerschbachJZurawBLCigarette smoke decreases innate responses of epithelial cells to rhinovirus infectionAm J Respir Cell Mol Biol201144111812620224072
   PubMed Web of Science ®Google Scholar
• GielenVSykesAZhuJIncreased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferonsJ Allergy Clin Immunol20151361177188.e1125630941
   PubMed Web of Science ®Google Scholar
• SiekmeierRLung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) – problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosisEur J Med Res201015Suppl 216417421147646
   PubMed Web of Science ®Google Scholar
• GrieseMLatzinPKapplerMalpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patientsEur Respir J200729224025017050563
   PubMed Web of Science ®Google Scholar
• SorrellsSCamprubiSGriffinRChenJAyguasanosaJSPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiencyRespir Med2015109449049925727857
   PubMed Web of Science ®Google Scholar
• GeraghtyPEdenEPillaiMCamposMMcElvaneyNGForonjyRFalpha1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responsesAm J Respir Crit Care Med2014190111229124225341065
   PubMed Web of Science ®Google Scholar
• ChurgADaiJZayKAlpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effectsLab Invest20018181119113111502863
   PubMed Web of Science ®Google Scholar
• LupferCMalikAKannegantiTDInflammasome control of viral infectionCurr Opin Virol201512384625771504
   PubMed Web of Science ®Google Scholar
• GastaldelloSChenXCallegariSMasucciMGCaspase-1 promotes Epstein-Barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cellsPLoS Pathog2013910e100366424130483
   PubMed Web of Science ®Google Scholar
• WangYHeYAbrahamBCytosolic, autocrine alpha-1 proteinase inhibitor (A1PI) inhibits caspase-1 and blocks IL-1beta dependent cytokine release in monocytesPLoS One2012711e5107823226468
   PubMed Web of Science ®Google Scholar
• RahmanMAMitraSSarkarAWewersMDAlpha 1-antitrypsin does not inhibit human monocyte caspase-1PLoS One2015102e011733025658455
   PubMed Web of Science ®Google Scholar
• LiebermanJAugmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting dataChest200011851480148511083705
   PubMed Web of Science ®Google Scholar
• CamposMAKueppersFStocksJMSafety and pharmacokinetics of 120 mg/kg versus 60 mg/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)COPD201310668769523862647
   PubMedGoogle Scholar
• StollerJKFallatRSchluchterMDAugmentation therapy with alpha1-antitrypsin: patterns of use and adverse eventsChest200312351425143412740257
   PubMed Web of Science ®Google Scholar
• KueppersFThe role of augmentation therapy in alpha-1 antitrypsin deficiencyCurr Med Res Opin201127357958821226542
   PubMed Web of Science ®Google Scholar
• MarciniukDDHernandezPBalterMCanadian Thoracic Society COPD Clinical Assembly Alpha-1 Antitrypsin Deficiency Expert Working GroupAlpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guidelineCan Respir J201219210911622536580
   PubMed Web of Science ®Google Scholar
• StockleyRAEmerging drugs for alpha-1-antitrypsin deficiencyExpert Opin Emerg Drugs201015468569420716026
   PubMed Web of Science ®Google Scholar